The Beat AML program produced a comprehensive dataset on acute myeloid leukemia (AML) that included genomic data (i.e., whole-exome sequencing and RNA sequencing), ex vivo drug response, and clinical data. We have included only the drug response data from this program in this package.
beatAMLA tibble with three variables:
inhibitornames of inhibitors
patient_idanonymous patient ID
medianthe median of drug response at corresponding inhibitor and patient_id